Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...

The device, Varipulse, is a pulsed field ablation system which uses small burns or freezes to cause some scarring in the ...

FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

The Affera mapping and ablation system is the first on the market that can deliver both pulsed-field and radiofrequency ...

Woodland Heights Medical Center is pleased to announce treatment of its first patient with a new system that used Pulsed ...

Now, all three are feeling more energetic with fewer, if any, episodes of atrial fibrillation since having a pulsed field ablation (PFA). “Before, I was so exhausted. I would just sleep and not ...

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.